| Federal Supply and Demand of Isotopes |
Committee, Work group, Advisory group, or Task Force |
FDA |
NCI, NIBIB |
A workshop on Isotope Federal Supply and Demand is held annually. The workgroup that organizes this workshop consists of representatives of federal agencies with the aim of providing a forum for interaction between agencies, departments, and medical societies to communicate about potential shortages of isotopes that are of strategic importance to the nation including the availability of medical isotopes. Also, a report of isotope supply and demand and whether needs are commercially available is compiled by the National Institutes of Health (NIH) and submitted to DOE annually. The report includes demand for NIH intramural research programs and NIH extramural projects (grantees). Not included in this report are NIH intramural research needs that are supplied by its cyclotron or isotope needs to be met by commercial suppliers. NIH collects data from ICs and submits annual reports as required. On January 12, 2021, DOE, NIH, and the members of the Isotope Needs Program held the 7th Workshop on Isotope Federal Supply and Demand. The meeting reviewed the Program’s ongoing activities and reported that the newly evolving use of electron- and alpha-emitting isotopes are seeing increased need (based on FDA’s approval for medical applications); the DOE is developing a plan to meet the current and foreseen increased use of these isotopes for cancer therapy. In support of these efforts, NIBIB conducted an August 16-17, 2021, workshop that focused on instrumentation development to directly image these new electron- and alpha-emitting isotopes for enhancing cancer therapy outcomes. |
| Federal Tobacco Cessation Workgroup |
Committee, Work group, Advisory group, or Task Force |
AHRQ, CDC, CMS, FDA, HRSA, OASH, SAMHSA |
NCI, NIDA, NIMHD |
Monthly meeting of Federal staff who have a focus on and interest in tobacco cessation efforts. Discusses tobacco cessation strategies, opportunities for collaborations among HHS agencies, and the newest evidence around tobacco cessation research. |
| Federal Tuberculosis Task Force |
Committee, Work group, Advisory group, or Task Force |
CDC, AHRQ, CMS, FDA, HRSA, IHS, OS |
NIAID, NICHD |
The Federal Tuberculosis (TB) Task Force is a coalition composed of the federal agencies involved in U.S. TB research and control efforts. Established in 1991, it facilitates coordination of activities among these federal agencies. |
| Federal Web Archiving Interest Group |
Committee, Work group, Advisory group, or Task Force |
ASPA |
NLM |
The Federal Web Archiving Interest Group shares strategies, workflows, and best practices for collecting, preserving, and providing access to archived web content of interest to U.S. federal agencies. As needed, smaller working groups may form to advance joint projects. The main goal of this interest group is to serve as a forum for discussing current and future web archiving projects, fostering collaboration, and providing mutual support across the federal government, while also minimizing unnecessary duplication of efforts. https://siarchives.si.edu/about/partnerships/fedweb |
| Federal Working Group on Bone Diseases (FWGBD) |
Committee, Work group, Advisory group, or Task Force |
CDC, CMS, FDA |
NIA, NIAMS, NICHD, NIDCR, NIDDK, OD/DPCPSI/ORWH |
An interagency committee focusing on osteoporosis and other bone disorders. It offers a forum for sharing information, learning from each other and invited speakers, and facilitating the development, early in the planning stages, of collaborative research activities based on each agency's mission. |
| Federated learning across Health Information Exchanges (HIE) |
Committee, Work group, Advisory group, or Task Force |
ONC |
NCI |
In cooperation with the Nebraska Health Information Initiative (NEHII) and the National Cancer Institute (NCI), NIH launched a pilot program earlier this year that uses a machine learning concept known as federated learning that could leverage existing HIE data while ensuring privacy. Federated learning is a machine learning technique that shares an analytical model between different groups, allowing them to analyze their own data – and share those results – without needing to share the actual raw data.The pilot aimed to expand clinical insights regarding COVID-19 using the existing ways health data are stored and protected in the US. In our pilot, each organization connected to a central cloud ecosystem known as the Multi-state Federated Architecture for Shared Analytics, better known as MuFASA. |
| Federated Linked Data System Working Group |
Committee, Work group, Advisory group, or Task Force |
CDC, CMS, FDA, OS |
NCI |
Provide feedback and guidance for the legal and governance framework of a federated linked data system |
| Fellowship in Genomic Science and Health Equity |
Training Initiative |
FDA |
NHGRI |
The FDA's Office of Minority Health and Health Equity and the NHGRI jointly sponsor a fellowship program for masters and postdoctoral level scholars to provide training in genetic, genomic, and pharmacogenomic approaches to advance minority health and health equity. Working closely with mentors at both the FDA and NIH, this program helps fellows learn to bridge research, development and review processes, advance their knowledge of health disparities, and build awareness of regulatory sciences. |
| Filovirus Animal Non-Clinical Group (FANG) |
Committee, Work group, Advisory group, or Task Force |
CDC, FDA, OS |
NIAID |
The Filovirus Animal Non-Clinical Group (FANG) focuses on the advanced development of Filovirus medical countermeasures (MCM), both vaccines and therapeutics. The FANG focuses on the product development tools and other interagency product development issues relevant to FDA approval of filovirus MCM. A standing interagency working group, the Portfolio Advisory Committee, oversees the FANG. The FANG will develop strategies to address broadly applicable and interagency product development issues relevant to licensure of filovirus MCM. The FANG will develop consensus recommendations to facilitate standardization of reagents, methods, and procedures across multiple agencies and laboratories. |
| Flow Cytometry Interest Group |
Committee, Work group, Advisory group, or Task Force |
FDA |
NCI, NEI, NHLBI, NIAID, NIAMS, NIDCR |
The NIH Flow Cytometry Interest Group, an NIH-affiliated scientific interest group supported by the NIH Office of the Director, provides central information for basic and clinical investigators doing flow and image cytometry at NIH. The group sponsors two meetings a year on the science and technology of cytometry, and is a central clearinghouse for cytometry resources at NIH. |